The City of Baltimore has joined the thousands of plaintiffs seeking financial compensation for cancer allegedly caused by exposure to a hidden carcinogen in the popular heartburn drug Zantac (ranitidine). In this post we will look at the odd nature of the Zantac lawsuit filed by the City of Baltimore and evaluate its chances of success.
About the Zantac Cancer Lawsuits
Zantac is the popular brand name for ranitidine, an antacid drug used for the treatment of heart burn, indigestion and other common conditions. Zantac and generic ranitidine had been around for decades in both over-the-counter and prescription forms. It was one of the most commonly used medications in the U.S. Over 10 million people used Zantac on a regular basis.